{{Rsnum
|rsid=1690916
|Gene=MDM2
|Chromosome=12
|position=68841626
|Orientation=plus
|GMAF=0.3072
|Gene_s=MDM2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 51.3 | 23.9
| HCB | 4.4 | 37.2 | 58.4
| JPT | 4.4 | 39.8 | 55.8
| YRI | 6.1 | 34.7 | 59.2
| ASW | 10.5 | 21.1 | 68.4
| CHB | 4.4 | 37.2 | 58.4
| CHD | 7.4 | 36.1 | 56.5
| GIH | 7.9 | 35.6 | 56.4
| LWK | 1.8 | 22.7 | 75.5
| MEX | 6.9 | 41.4 | 51.7
| MKK | 10.3 | 42.6 | 47.1
| TSI | 8.8 | 43.1 | 48.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23113306
|Title=Association of FGFR3 and MDM2 Gene Nucleotide Polymorphisms with Bone Tumors
}}

{{PMID Auto
|PMID=23979978
|Title=Polymorphisms in the MDM2 gene and risk of malignant bone tumors: a meta-analysis
}}

{{PMID Auto
|PMID=24640097
|Title=Associations of single nucleotide polymorphisms with malignant and borderline bone tumors
}}
{{on chip | Illumina Human 1M}}